v3.24.3
SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of the Weighted Average Fair Value of Stock Options Granted, the Total Intrinsic Value of Stock Options Exercised and the Fair Value of Options Vested
The following table summarizes the grant date fair value of stock options that vested during the periods presented:
 Nine months ended September 30,
(in thousands, except per share data)20242023
Weighted average grant date fair value of stock options granted per share$— $— 
Intrinsic value of options exercised— — 
Grant date fair value of stock options that vested83 83 
Schedule of the Activity of the Entity's Stock Options
The following table summarizes the activity related to our stock options:
 Number of optionsWeighted average exercise price
Weighted average contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding as of December 31, 2023739,189 $27.04 4.83$— 
Granted— — 
Forfeited(27,500)81.44   
Outstanding as of September 30, 2024711,689 24.94 3.21— 
Exercisable as of September 30, 2024543,200 24.34 2.61— 
Schedule of Restricted Stock and Restricted Stock Units Activity
The following table summarizes the activity related to our restricted shares and restricted share units:
Number of restricted shares and restricted share units
Outstanding as of December 31, 20231,262,742 
Granted1,637,880 
Issued(578,325)
Forfeited/canceled(319,708)
Outstanding as of September 30, 20242,002,589